{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T15:32:51Z","timestamp":1791300771864,"version":"4.1.0"},"reference-count":62,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales de Cardiologie et d'Ang\u00e9iologie"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.ancard.2018.04.018","type":"journal-article","created":{"date-parts":[[2018,5,22]],"date-time":"2018-05-22T04:28:58Z","timestamp":1526963338000},"page":"141-148","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Cons\u00e9quences cardiovasculaires de l\u2019insuffisance r\u00e9nale chronique, int\u00e9r\u00eat d\u2019une modulation des acides \u00e9poxyeicosatri\u00e9no\u00efques"],"prefix":"10.1016","volume":"67","author":[{"given":"M.","family":"Hamzaoui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Guerrot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z.","family":"Djerada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Duflot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Richard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Bellien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.ancard.2018.04.018_bib0315","doi-asserted-by":"crossref","first-page":"e0158765","DOI":"10.1371\/journal.pone.0158765","article-title":"Global prevalence of chronic kidney disease \u2013 a systematic review and meta-analysis","volume":"11","author":"Hill","year":"2016","journal-title":"PLoS ONE"},{"issue":"1","key":"10.1016\/j.ancard.2018.04.018_bib0320","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1161\/CIRCULATIONAHA.106.678342","article-title":"Chronic kidney disease: effects on the cardiovascular system","volume":"116","author":"Schiffrin","year":"2007","journal-title":"Circ"},{"issue":"7","key":"10.1016\/j.ancard.2018.04.018_bib0325","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1681\/ASN.2005101085","article-title":"Chronic kidney disease and mortality risk: a systematic review","volume":"17","author":"Tonelli","year":"2006","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"10.1016\/j.ancard.2018.04.018_bib0330","doi-asserted-by":"crossref","first-page":"S112","DOI":"10.1053\/ajkd.1998.v32.pm9820470","article-title":"Clinical epidemiology of cardiovascular disease in chronic renal disease","volume":"32","author":"Foley","year":"1998","journal-title":"American J Kidney Dis"},{"issue":"13","key":"10.1016\/j.ancard.2018.04.018_bib0335","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1056\/NEJMoa041031","article-title":"Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization","volume":"351","author":"Go","year":"2004","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.ancard.2018.04.018_bib0340","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1681\/ASN.2012020145","article-title":"Associations between kidney function and subclinical cardiac abnormalities in CKD","volume":"23","author":"Park","year":"2012","journal-title":"J Am Soc Nephrol"},{"issue":"19","key":"10.1016\/j.ancard.2018.04.018_bib0345","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1016\/j.jacc.2008.07.051","article-title":"Cardiorenal syndrome","volume":"52","author":"Ronco","year":"2008","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.ancard.2018.04.018_bib0350","doi-asserted-by":"crossref","first-page":"93","DOI":"10.2515\/therapie\/2009014","article-title":"New pharmacological approaches in heart failure: should we treat the endothelium?","volume":"64","author":"Richard","year":"2009","journal-title":"Therapie"},{"issue":"7","key":"10.1016\/j.ancard.2018.04.018_bib0355","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/S0735-1097(03)00994-X","article-title":"The clinical implications of endothelial dysfunction","volume":"42","author":"Widlansky","year":"2003","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.ancard.2018.04.018_bib0360","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pharmthera.2011.03.015","article-title":"Modulation of cytochrome-derived epoxyeicosatrienoic acids pathway: a promising pharmacological approach to prevent endothelial dysfunction in cardiovascular diseases?","volume":"131","author":"Bellien","year":"2011","journal-title":"Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.ancard.2018.04.018_bib0365","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1152\/physrev.00021.2011","article-title":"Epoxides and soluble epoxide hydrolase in cardiovascular physiology","volume":"92","author":"Imig","year":"2012","journal-title":"Physiol Rev"},{"issue":"3","key":"10.1016\/j.ancard.2018.04.018_bib0370","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1517\/17460441.2014.881354","article-title":"Design and discovery of soluble epoxide hydrolase inhibitors for the treatment of cardiovascular diseases","volume":"9","author":"Duflot","year":"2014","journal-title":"Expert Opin Drug Discov"},{"issue":"7","key":"10.1016\/j.ancard.2018.04.018_bib0375","doi-asserted-by":"crossref","first-page":"3460","DOI":"10.1074\/jbc.271.7.3460","article-title":"Molecular cloning and expression of CYP2J2, a human cytochrome P450\u00a0arachidonic acid epoxygenase highly expressed in heart","volume":"271","author":"Wu","year":"1996","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1016\/j.ancard.2018.04.018_bib0380","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0163-7827(03)00049-3","article-title":"Epoxyeicosatrienoic acids (EETs): metabolism and biochemical function","volume":"43","author":"Spector","year":"2004","journal-title":"Prog Lipid Res"},{"issue":"1","key":"10.1016\/j.ancard.2018.04.018_bib0385","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1161\/01.RES.60.1.50","article-title":"Intestinal vasodilation by epoxyeicosatrienoic acids: arachidonic acid metabolites produced by a cytochrome P450\u00a0monooxygenase","volume":"60","author":"Proctor","year":"1987","journal-title":"Circ Res"},{"issue":"3","key":"10.1016\/j.ancard.2018.04.018_bib0390","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1161\/01.RES.78.3.415","article-title":"Identification of epoxyeicosatrienoic acids as endothelium-derived hyperpolarizing factors","volume":"78","author":"Campbell","year":"1996","journal-title":"Circ Res"},{"issue":"10","key":"10.1016\/j.ancard.2018.04.018_bib0395","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1161\/CIRCULATIONAHA.111.070680","article-title":"Epoxyeicosatrienoic acids contribute with altered nitric oxide and endothelin-1\u00a0pathways to conduit artery endothelial dysfunction in essential hypertension","volume":"125","author":"Bellien","year":"2012","journal-title":"Circ"},{"issue":"9","key":"10.1016\/j.ancard.2018.04.018_bib0400","doi-asserted-by":"crossref","first-page":"e46065","DOI":"10.1371\/journal.pone.0046065","article-title":"11,12-EET stimulates the association of BK channel \u03b1 and \u03b2(1) subunits in mitochondria to induce pulmonary vasoconstriction","volume":"7","author":"Loot","year":"2012","journal-title":"PLoS ONE"},{"issue":"2","key":"10.1016\/j.ancard.2018.04.018_bib0405","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1097\/FJC.0b013e3181ed088d","article-title":"Cytochrome P450-derived epoxyeicosatrienoic acids and pulmonary hypertension: central role of transient receptor potential C6\u00a0channels","volume":"57","author":"Loot","year":"2011","journal-title":"J Cardiovasc Pharmacol"},{"issue":"5431","key":"10.1016\/j.ancard.2018.04.018_bib0410","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1126\/science.285.5431.1276","article-title":"Anti-inflammatory properties of cytochrome P450\u00a0epoxygenase-derived eicosanoids","volume":"285","author":"Node","year":"1999","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.ancard.2018.04.018_bib0415","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1096\/fj.10-171488","article-title":"Endothelial CYP epoxygenase overexpression and soluble epoxide hydrolase disruption attenuate acute vascular inflammatory responses in mice","volume":"25","author":"Deng","year":"2011","journal-title":"FASEB J"},{"key":"10.1016\/j.ancard.2018.04.018_bib0420","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/bs.apha.2016.04.003","article-title":"Epoxyeicosatrienoic acids and 20-Hydroxyeicosatetraenoic acid on endothelial and vascular function","volume":"77","author":"Imig","year":"2016","journal-title":"Adv Pharmacol"},{"issue":"1\u20134","key":"10.1016\/j.ancard.2018.04.018_bib0425","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.prostaglandins.2006.05.003","article-title":"Epoxyeicosatrienoic acids, cell signaling and angiogenesis","volume":"82","author":"Fleming","year":"2007","journal-title":"Prostaglandins Other Lipid Mediat"},{"issue":"5","key":"10.1016\/j.ancard.2018.04.018_bib0430","doi-asserted-by":"crossref","first-page":"C1292","DOI":"10.1152\/ajpcell.00230.2008","article-title":"Epoxyeicosatrienoic acids are part of the VEGF-activated signaling cascade leading to angiogenesis","volume":"295","author":"Webler","year":"2008","journal-title":"Am J Physiol, Cell Physiol"},{"issue":"2","key":"10.1016\/j.ancard.2018.04.018_bib0435","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/j.1476-5381.2008.00009.x","article-title":"Pharmacokinetic optimization of four soluble epoxide hydrolase inhibitors for use in a murine model of inflammation","volume":"156","author":"Liu","year":"2009","journal-title":"Br J Pharmacol"},{"issue":"4","key":"10.1016\/j.ancard.2018.04.018_bib0440","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.bbrc.2012.02.108","article-title":"Role of soluble epoxide hydrolase phosphatase activity in the metabolism of lysophosphatidic acids","volume":"419","author":"Morisseau","year":"2012","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"10.1016\/j.ancard.2018.04.018_bib0445","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1073\/pnas.0811022106","article-title":"Soluble epoxide hydrolase plays an essential role in angiotensin II-induced cardiac hypertrophy","volume":"106","author":"Ai","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"issue":"49","key":"10.1016\/j.ancard.2018.04.018_bib0450","doi-asserted-by":"crossref","first-page":"18733","DOI":"10.1073\/pnas.0609158103","article-title":"Prevention and reversal of cardiac hypertrophy by soluble epoxide hydrolase inhibitors","volume":"103","author":"Xu","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"10.1016\/j.ancard.2018.04.018_bib0455","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1097\/HJH.0b013e328345ef7b","article-title":"Soluble epoxide hydrolase inhibition prevents coronary endothelial dysfunction in mice with renovascular hypertension","volume":"29","author":"Gao","year":"2011","journal-title":"J Hypertens"},{"issue":"3","key":"10.1016\/j.ancard.2018.04.018_bib0460","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1093\/cvr\/cvv018","article-title":"Cardiomyocyte-specific expression of CYP2J2\u00a0prevents development of cardiac remodelling induced by angiotensin II","volume":"105","author":"He","year":"2015","journal-title":"Cardiovasc Res"},{"issue":"3","key":"10.1016\/j.ancard.2018.04.018_bib0465","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.yjmcc.2011.11.015","article-title":"Soluble epoxide hydrolase inhibition improves myocardial perfusion and function in experimental heart failure","volume":"52","author":"Merabet","year":"2012","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.ancard.2018.04.018_bib0470","doi-asserted-by":"crossref","first-page":"758614","DOI":"10.1155\/2012\/758614","article-title":"Pharmacological inhibition of soluble epoxide hydrolase ameliorates diet-induced metabolic syndrome in rats","volume":"2012","author":"Iyer","year":"2012","journal-title":"Exp Diabetes Res"},{"issue":"9","key":"10.1016\/j.ancard.2018.04.018_bib0475","doi-asserted-by":"crossref","first-page":"H1020","DOI":"10.1152\/ajpheart.00465.2014","article-title":"Soluble epoxide hydrolase inhibition improves coronary endothelial function and prevents the development of cardiac alterations in obese insulin-resistant mice","volume":"308","author":"Roche","year":"2015","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.ancard.2018.04.018_bib0480","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.freeradbiomed.2018.02.009","article-title":"CYP2J2-derived EETs attenuated ethanol-induced myocardial dysfunction through inducing autophagy and reducing apoptosis","volume":"117","author":"Zhou","year":"2018","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.ancard.2018.04.018_bib0485","doi-asserted-by":"crossref","first-page":"e885","DOI":"10.1038\/cddis.2013.418","article-title":"Epoxyeicosatrienoic acids protect cardiac cells during starvation by modulating an autophagic response","volume":"4","author":"Samokhvalov","year":"2013","journal-title":"Cell Death Dis"},{"issue":"10","key":"10.1016\/j.ancard.2018.04.018_bib0490","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1093\/hmg\/ddl085","article-title":"Genetic variation in soluble epoxide hydrolase (EPHX2) and risk of coronary heart disease: The Atherosclerosis Risk in Communities (ARIC) study","volume":"15","author":"Lee","year":"2006","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.ancard.2018.04.018_bib0495","doi-asserted-by":"crossref","DOI":"10.2215\/CJN.12551117","article-title":"BP measurement techniques: what they mean for patients with kidney disease","author":"Thomas","year":"2018","journal-title":"Clin J Am Soc Nephrol"},{"issue":"11","key":"10.1016\/j.ancard.2018.04.018_bib0500","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1161\/01.RES.87.11.992","article-title":"Soluble epoxide hydrolase regulates hydrolysis of vasoactive epoxyeicosatrienoic acids","volume":"87","author":"Yu","year":"2000","journal-title":"Circ Res"},{"issue":"51","key":"10.1016\/j.ancard.2018.04.018_bib0505","doi-asserted-by":"crossref","first-page":"40504","DOI":"10.1074\/jbc.M008106200","article-title":"Targeted disruption of soluble epoxide hydrolase reveals a role in blood pressure regulation","volume":"275","author":"Sinal","year":"2000","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1016\/j.ancard.2018.04.018_bib0510","doi-asserted-by":"crossref","first-page":"F342","DOI":"10.1152\/ajprenal.00004.2007","article-title":"Increasing or stabilizing renal epoxyeicosatrienoic acid production attenuates abnormal renal function and hypertension in obese rats","volume":"293","author":"Huang","year":"2007","journal-title":"Am J Physiol Renal Physiol"},{"issue":"2","key":"10.1016\/j.ancard.2018.04.018_bib0515","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1161\/hy0202.103788","article-title":"Soluble epoxide hydrolase inhibition lowers arterial blood pressure in Angiotensin II hypertension","volume":"39","author":"Imig","year":"2002","journal-title":"Hypertens"},{"issue":"11","key":"10.1016\/j.ancard.2018.04.018_bib0520","doi-asserted-by":"crossref","first-page":"3537","DOI":"10.1093\/ndt\/gfr081","article-title":"Vascular health, systemic inflammation and progressive reduction in kidney function; clinical determinants and impact on cardiovascular outcomes","volume":"26","author":"Yilmaz","year":"2011","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"10.1016\/j.ancard.2018.04.018_bib0525","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ejphar.2010.12.016","article-title":"Inhibition of soluble epoxide hydrolase attenuates endothelial dysfunction in animal models of diabetes, obesity and hypertension","volume":"654","author":"Zhang","year":"2011","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"10.1016\/j.ancard.2018.04.018_bib0530","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1161\/HYPERTENSIONAHA.110.161695","article-title":"Genetic variation in soluble epoxide hydrolase (EPHX2) is associated with forearm vasodilator responses in humans","volume":"57","author":"Lee","year":"2011","journal-title":"Hypertens"},{"issue":"Suppl 3","key":"10.1016\/j.ancard.2018.04.018_bib0535","first-page":"5","article-title":"Risk factors for atherosclerotic disease: present and future","volume":"31","author":"Vinereanu","year":"2006","journal-title":"Herz"},{"issue":"7","key":"10.1016\/j.ancard.2018.04.018_bib0540","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1093\/ndt\/gfu038","article-title":"Prevalence of subclinical atheromatosis and associated risk factors in chronic kidney disease: the NEFRONA study","volume":"29","author":"Betriu","year":"2014","journal-title":"Nephrol Dial Transplant"},{"issue":"4","key":"10.1016\/j.ancard.2018.04.018_bib0545","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1097\/FJC.0b013e318185fa3c","article-title":"Soluble epoxide hydrolase inhibitors reduce the development of atherosclerosis in apolipoprotein e-knockout mouse model","volume":"52","author":"Ulu","year":"2008","journal-title":"J Cardiovasc Pharmacol"},{"issue":"9","key":"10.1016\/j.ancard.2018.04.018_bib0550","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1161\/ATVBAHA.109.186064","article-title":"Inhibition of soluble epoxide hydrolase attenuated atherosclerosis, abdominal aortic aneurysm formation, and dyslipidemia","volume":"29","author":"Zhang","year":"2009","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"3","key":"10.1016\/j.ancard.2018.04.018_bib0555","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1161\/01.CIR.0000109487.46725.02","article-title":"Polymorphism of the soluble epoxide hydrolase is associated with coronary artery calcification in African-American subjects: The Coronary Artery Risk Development in Young Adults (CARDIA) study","volume":"109","author":"Fornage","year":"2004","journal-title":"Circ"},{"issue":"2","key":"10.1016\/j.ancard.2018.04.018_bib0560","doi-asserted-by":"crossref","first-page":"128","DOI":"10.3132\/dvdr.2008.021","article-title":"Genetic analysis of the soluble epoxide hydrolase gene EPHX2, in subclinical cardiovascular disease in the Diabetes Heart Study","volume":"5","author":"Burdon","year":"2008","journal-title":"Diab Vasc Dis Res"},{"issue":"3","key":"10.1016\/j.ancard.2018.04.018_bib0565","doi-asserted-by":"crossref","first-page":"F496","DOI":"10.1152\/ajprenal.00350.2004","article-title":"Epoxide hydrolase and epoxygenase metabolites as therapeutic targets for renal diseases","volume":"289","author":"Imig","year":"2005","journal-title":"Am J Physiol Renal Physiol"},{"issue":"5","key":"10.1016\/j.ancard.2018.04.018_bib0570","first-page":"1244","article-title":"Soluble epoxide hydrolase inhibition protects the kidney from hypertension-induced damage","volume":"15","author":"Zhao","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.ancard.2018.04.018_bib0575","doi-asserted-by":"crossref","first-page":"3480","DOI":"10.2741\/2942","article-title":"Soluble epoxide hydrolase inhibitor AUDA, prevents early salt-sensitive hypertension","volume":"13","author":"Li","year":"2008","journal-title":"Front Biosci"},{"key":"10.1016\/j.ancard.2018.04.018_bib0580","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.prostaglandins.2015.04.011","article-title":"Impact of soluble epoxide hydrolase inhibition on early kidney damage in hyperglycemic overweight mice","volume":"120","author":"Roche","year":"2015","journal-title":"Prostaglandins Other Lipid Mediat"},{"issue":"8","key":"10.1016\/j.ancard.2018.04.018_bib0585","doi-asserted-by":"crossref","first-page":"F971","DOI":"10.1152\/ajprenal.00256.2014","article-title":"Inhibition of soluble epoxide hydrolase prevents renal interstitial fibrosis and inflammation","volume":"307","author":"Kim","year":"2014","journal-title":"Am J Physiol Renal Physiol"},{"issue":"8","key":"10.1016\/j.ancard.2018.04.018_bib0590","doi-asserted-by":"crossref","first-page":"e11979","DOI":"10.1371\/journal.pone.0011979","article-title":"Inhibition of the soluble epoxide hydrolase promotes albuminuria in mice with progressive renal disease","volume":"5","author":"Jung","year":"2010","journal-title":"PLoS ONE"},{"issue":"2","key":"10.1016\/j.ancard.2018.04.018_bib0595","doi-asserted-by":"crossref","first-page":"F168","DOI":"10.1152\/ajprenal.00129.2012","article-title":"Upregulation of soluble epoxide hydrolase in proximal tubular cells mediated proteinuria-induced renal damage","volume":"304","author":"Wang","year":"2013","journal-title":"Am J Physiol Renal Physiol"},{"issue":"5","key":"10.1016\/j.ancard.2018.04.018_bib0600","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1016\/j.transproceed.2008.03.137","article-title":"Genetic variations in soluble epoxide hydrolase and graft function in kidney transplantation","volume":"40","author":"Lee","year":"2008","journal-title":"Transplant Proc"},{"issue":"6","key":"10.1016\/j.ancard.2018.04.018_bib0605","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1085\/jgp.200409140","article-title":"Arachidonic acid inhibits epithelial Na channel via cytochrome P450 (CYP) epoxygenase-dependent metabolic pathways","volume":"124","author":"Wei","year":"2004","journal-title":"J Gen Physiol"},{"issue":"6","key":"10.1016\/j.ancard.2018.04.018_bib0610","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1172\/JCI117608","article-title":"Experimental and\/or genetically controlled alterations of the renal microsomal cytochrome P450\u00a0epoxygenase induce hypertension in rats fed a high salt diet","volume":"94","author":"Makita","year":"1994","journal-title":"J Clin Invest"},{"issue":"3","key":"10.1016\/j.ancard.2018.04.018_bib0615","doi-asserted-by":"crossref","first-page":"F672","DOI":"10.1152\/ajprenal.00597.2010","article-title":"Effects of cytochrome P-450\u00a0metabolites of arachidonic acid on the epithelial sodium channel (ENaC)","volume":"301","author":"Pavlov","year":"2011","journal-title":"Am J Physiol Renal Physiol"},{"issue":"6","key":"10.1016\/j.ancard.2018.04.018_bib0310","doi-asserted-by":"crossref","first-page":"R1468","DOI":"10.1152\/ajpregu.00215.2010","article-title":"Role of cytochrome P-450\u00a0metabolites in the regulation of renal function and blood pressure in 2-kidney 1-clip hypertensive rats","volume":"300","author":"Sporkov\u00e1","year":"2011","journal-title":"Am J Physiol Regul Integr Comp Physiol"}],"container-title":["Annales de Cardiologie et d'Ang\u00e9iologie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003392818300623?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003392818300623?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,6,16]],"date-time":"2018-06-16T06:17:30Z","timestamp":1529129850000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003392818300623"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":62,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["S0003392818300623"],"URL":"https:\/\/doi.org\/10.1016\/j.ancard.2018.04.018","relation":{},"ISSN":["0003-3928"],"issn-type":[{"value":"0003-3928","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cons\u00e9quences cardiovasculaires de l\u2019insuffisance r\u00e9nale chronique, int\u00e9r\u00eat d\u2019une modulation des acides \u00e9poxyeicosatri\u00e9no\u00efques","name":"articletitle","label":"Article Title"},{"value":"Annales de Cardiologie et d'Ang\u00e9iologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ancard.2018.04.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}